NASDAQ:BMTI - BioMimetic Therapeutics Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioMimetic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BioMimetic Therapeutics, Inc is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company's Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:BMTI Previous Symbol CUSIPN/A CIK1138400 Webhttp://biomimetics.com/ Phone+1-615-8441280Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive BMTI News and Ratings via Email Sign-up to receive the latest news and ratings for BMTI and its competitors with MarketBeat's FREE daily newsletter. BioMimetic Therapeutics (NASDAQ:BMTI) Frequently Asked Questions What is BioMimetic Therapeutics' stock symbol? BioMimetic Therapeutics trades on the NASDAQ under the ticker symbol "BMTI." Has BioMimetic Therapeutics been receiving favorable news coverage? News stories about BMTI stock have been trending very positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioMimetic Therapeutics earned a coverage optimism score of 3.1 on InfoTrie's scale. They also gave media stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for BioMimetic Therapeutics. What is BioMimetic Therapeutics' official website? The official website for BioMimetic Therapeutics is http://biomimetics.com/. How can I contact BioMimetic Therapeutics? BioMimetic Therapeutics' mailing address is 389 Nichol Mill Lane, FRANKLIN, TN 37067, United States. The biotechnology company can be reached via phone at +1-615-8441280. MarketBeat Community Rating for BioMimetic Therapeutics (NASDAQ BMTI)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 71 (Thanks for Voting!)Underperform Votes: 82 (Thanks for Voting!)Total Votes: 153MarketBeat's community ratings are surveys of what our community members think about BioMimetic Therapeutics and other stocks. Vote "Outperform" if you believe BMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMTI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2020 by MarketBeat.com StaffFeatured Article: What is a support level?